The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs

ST Diepstraten, MA Anderson, PE Czabotar… - Nature Reviews …, 2022 - nature.com
Apoptosis is a form of programmed cell death that is regulated by the balance between
prosurvival and proapoptotic BCL-2 protein family members. Evasion of apoptosis is a …

Emerging connectivity of programmed cell death pathways and its physiological implications

S Bedoui, MJ Herold, A Strasser - Nature reviews Molecular cell biology, 2020 - nature.com
The removal of functionally dispensable, infected or potentially neoplastic cells is driven by
programmed cell death (PCD) pathways, highlighting their important roles in homeostasis …

Targeting MCL-1 in cancer: current status and perspectives

H Wang, M Guo, H Wei, Y Chen - Journal of hematology & oncology, 2021 - Springer
Abstract Myeloid leukemia 1 (MCL-1) is an antiapoptotic protein of the BCL-2 family that
prevents apoptosis by binding to the pro-apoptotic BCL-2 proteins. Overexpression of MCL …

Cell death pathways: intricate connections and disease implications

M Kist, D Vucic - The EMBO Journal, 2021 - embopress.org
Various forms of cell death have been identified over the last decades with each relying on a
different subset of proteins for the activation and execution of their respective pathway (s). In …

Mitochondria as playmakers of apoptosis, autophagy and senescence

M Abate, A Festa, M Falco, A Lombardi, A Luce… - Seminars in cell & …, 2020 - Elsevier
Mitochondria are the key energy-producing organelles and cellular source of reactive
species. They are responsible for managing cell life and death by a balanced homeostasis …

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

AE Tron, MA Belmonte, A Adam, BM Aquila… - Nature …, 2018 - nature.com
Mcl-1 is a member of the Bcl-2 family of proteins that promotes cell survival by preventing
induction of apoptosis in many cancers. High expression of Mcl-1 causes tumorigenesis and …

Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia

P Blombery, MA Anderson, J Gong, R Thijssen… - Cancer discovery, 2019 - AACR
The BCL2 inhibitor venetoclax induces high rates of durable remission in patients with
previously treated chronic lymphocytic leukemia (CLL). However, despite continuous daily …

[HTML][HTML] Cell death in the origin and treatment of cancer

A Strasser, DL Vaux - Molecular cell, 2020 - cell.com
Cell death, or, more specifically, cell suicide, is a process of fundamental importance to
human health. Throughout our lives, over a million cells are produced every second. When …

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

A Kotschy, Z Szlavik, J Murray, J Davidson… - Nature, 2016 - nature.com
Avoidance of apoptosis is critical for the development and sustained growth of tumours. The
pro-survival protein myeloid cell leukemia 1 (MCL1) is overexpressed in many cancers, but …

The BCL-2 arbiters of apoptosis and their growing role as cancer targets

JM Adams, S Cory - Cell Death & Differentiation, 2018 - nature.com
Impaired apoptosis plays a central role in cancer development and limits the efficacy of
conventional cytotoxic therapies. Deepening understanding of how opposing factions of the …